Research suggests that a newly identified gene known as insomniac is an important reason why we get drowsy and fall asleep. By cloning and testing this gene in fruit flies, Rockefeller University researchers say they have discovered an entirely new mechanism by which sleep is regulated. More »
Categories
Archive





















Cancer cells are most deadly when they’re on the move – able not only to destroy whatever organ they are first formed in, but also to create colonies elsewhere in the body. New research has now shown how a small RNA prevents the recruitment and formation of blood vessels near cancer cell destined to become metastases, a process that must occur in order for them to grow. The scientists say that if drugs could be developed that act on the pathways regulated by this microRNA, they might be able to block the metastatic process and prevent some breast cancers from becoming deadly.
Tomorrow, the family of Nobel Prize winner Ralph M. Steinman, who died September 30, will accept the Nobel medal and diploma on his behalf from King Carl XVI Gustaf of Sweden. The ceremony will be Webcast live beginning at 10:20 a.m. Eastern Time. A video of the Nobel Prize Award Ceremony will also be available a few days later.
Although only five percent of people in clinical trials report side effects from statin drugs, in practice the problem is far greater. Clinical trials need to better address the needs of statin-intolerant patients, Rockefeller researchers say.
The New York Genome Center, which will become one of the largest genomic facilities in North America, will begin operations as early as spring 2012 in its 120,000 square foot Manhattan facility.
A world leader in the study of brain development, Tessier-Lavigne has pioneered the identification of the molecules that direct the formation of connections among nerve cells to establish neuronal circuits in the mammalian brain and spinal cord. Tessier-Lavigne is among 65 new members and five foreign associates elected to the Institute this year.
Thomas Perlmann, a neurobiologist at the Karolinska Institute who studies the dopamine-producing cells that die during the development of Parkinson’s disease, will visit the Rockefeller University campus this week and give the Nicholson Lecture on Friday. The lecture is part of a recently renewed program that supports research exchanges between the university and the Karolinska Institute.
Michael W. Young will share Columbia University’s Louisa Gross Horwitz Prize with with Jeffrey C. Hall and Michael Rosbash for their work on the molecular basis of circadian rhythms. His research provides a basis for the development of possible treatments for hereditary sleep disorders in humans.
Rockefeller University cell biologist Ralph M. Steinman, who discovered the immune system’s sentinel dendritic cells and demonstrated that science can fruitfully harness the power of these cells and other components of the immune system to curb infections and other communicable diseases, is this year’s recipient of the Nobel Prize in Physiology or Medicine, the Nobel Foundation in Stockholm, Sweden, announced today. He shares half the prize with Bruce A. Beutler and Jules A. Hoffmann. 
Unlisted ingredients identified by DNA barcoding technology include weeds such as annual bluegrass and herbal plants such as chamomile. Though mostly harmless, the surprise ingredients could affect a tiny minority of consumers with acute allergies.
A team of researchers led by scientists in the Laboratory of Virology and Infectious Disease at Rockefeller have, for the first time, recreated a portion of the hepatitis C virus life cycle in a mouse with a functional immune system. The new mouse model will enable scientists to test molecules that block entry of the hepatitis C virus into cells as well as potential vaccine candidates. 


